These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10403067)

  • 1. Migraine prescription density and recommendations. Results of the PCAOM Study.
    Krobot KJ; Steinberg HW; Pfaffenrath V
    Cephalalgia; 1999 Jun; 19(5):511-9. PubMed ID: 10403067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription Patterns and the Cost of Migraine Treatments in German General and Neurological Practices.
    Jacob L; Kostev K
    Pain Pract; 2017 Jul; 17(6):747-752. PubMed ID: 27622427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disparity in access to new medication by type of health insurance: lessons from Germany.
    Krobot KJ; Miller WC; Kaufman JS; Christensen DB; Preisser JS; Ibrahim MA
    Med Care; 2004 May; 42(5):487-91. PubMed ID: 15083110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
    Jünger C; Rathmann W; Giani G
    Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysis.
    Roessler T; Zschocke J; Roehrig A; Friedrichs M; Friedel H; Katsarava Z
    J Headache Pain; 2020 Jul; 21(1):85. PubMed ID: 32631274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray.
    Hoffman L; Mayzell G; Pedan A; Farrell M; Gilbert T
    J Manag Care Pharm; 2003; 9(4):335-45. PubMed ID: 14613452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine consultation patterns in primary care. Results from the PCAOM study 1994-96.
    Krobot KJ; Schröder-Bernhardi D; Pfaffenrath V
    Cephalalgia; 1999 Nov; 19(9):831-40. PubMed ID: 10595294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
    Ng-Mak DS; Chen YT; Ho TW; Stanford B; Roset M
    Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care resource utilization following initiation of a triptan: a retrospective claims analysis.
    Messali A; Owens G; Bloudek L; Kori S; Cole A; Chia J
    J Manag Care Spec Pharm; 2014 Apr; 20(4):368-75. PubMed ID: 24684641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimigraine medication use and associated health care costs in employed patients.
    Wu J; Hughes MD; Hudson MF; Wagner PJ
    J Headache Pain; 2012 Mar; 13(2):121-7. PubMed ID: 22127427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and burden of headache and migraine in Germany.
    Radtke A; Neuhauser H
    Headache; 2009 Jan; 49(1):79-89. PubMed ID: 19125877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug use and costs among diabetic patients in primary health care practices in Germany.
    Rathmann W; Haastert B; Roseman JM; Gries FA; Giani G
    Diabetes Care; 1998 Mar; 21(3):389-97. PubMed ID: 9540021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population.
    Latinovic R; Gulliford M; Ridsdale L
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):385-7. PubMed ID: 16484650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug prescriptions and costs in diabetic polyneuropathy].
    Rathmann W; Haastert B; Giani G
    Dtsch Med Wochenschr; 1999 Jun; 124(22):681-6. PubMed ID: 10394347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey.
    Devine JW; Farley JF; Hadsall RS
    Headache; 2005 Oct; 45(9):1171-80. PubMed ID: 16178947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of osteopathic manipulative treatment on cost of care for patients with migraine headache: a retrospective review of patient records.
    Schabert E; Crow WT
    J Am Osteopath Assoc; 2009 Aug; 109(8):403-7. PubMed ID: 19706829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.